🇺🇸
United States · US · US:43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4
GaviLyte-H and Bisacodyl
Orange BookSPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerLupin Pharmaceuticals, Inc.
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1143386071831 KIT in 1 KIT (43386-071-83) * 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (43386-010-61) * 2 L in 1 BOTTLE (43386-070-17)
Annotations
Orange Book
A202217
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"route": "ORAL",
"spl_meta": {
"78fe1c29-e22a-4615-a2f9-a61cd4eb38a3": {
"match": "brand_token",
"title": "GAVILYTE-H AND BISACODYL (POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET) KIT [LUPIN PHARMACEUTICALS, INC.]",
"spl_version": "3",
"published_date": "2025-01-30"
}
},
"productid": "43386-071_c34cfe17-96c2-4f07-8a2d-74bc84e61fb4",
"productndc": "43386-071",
"dosage_form": "KIT",
"orange_book": {
"appl_no": "202217",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM",
"product_no": "001",
"approval_date": "Aug 20, 2014"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": null,
"proprietary_name": "GaviLyte-H and Bisacodyl",
"active_ingred_unit": null,
"application_number": "ANDA202217",
"marketing_category": "ANDA",
"nonproprietary_name": "Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet",
"start_marketing_date": "20150421",
"active_numerator_strength": null
}Access this data programmatically
Query GaviLyte-H and Bisacodyl and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.